Tag: UroGen Pharma Ltd.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. – URGN

NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of UroGen Pharma Ltd. ("UroGen" or the "Company") (NASDAQ: URGN). Such investors...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsUroGen Pharma Ltd.

BOSTON PIZZA ROYALTIES INCOME FUND ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING VOTING

Ceres Global Ag Corp. Receives Final Order for Arrangement with Bartlett Grain Company

EQV Ventures Acquisition Corp. II Announces Closing of Upsized $460 Million Initial Public Offering and Partial Exercise of Over-Allotment Option

Tag: UroGen Pharma Ltd.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. – URGN

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us